Who is sponsoring NCT04749615?

NCT04749615 is sponsored by Hospital for Special Surgery, New York.

What condition does NCT04749615 study?

NCT04749615 studies Total Knee Athroplasty.

What drugs are being tested in NCT04749615?

Interventions: Periarticular Injection (PAI), Saline Control Periarticular Injection (PAI).

What is the status of NCT04749615?

NCT04749615 is currently COMPLETED.

Last reviewed 2024-12-27 · How we verify

Does PAI Reduce Pain After TKA Among Knee Arthroplasty Patients Receiving ACB & IPACK?

NCT04749615 PHASE4 COMPLETED Results posted

The goal of this clinical trial is to determine whether Periarticular Injection (PAI) alongside Adductor Canal Block (ACB) and Infiltration between the Popliteal Artery and Capsule of the Knee (IPACK) block can decrease post-operative pain in patients undergoing primary total knee arthroplasty. The main question it aims to answer is: • Is ACB/IPACK without PAI as effective as ACB/IPACK with PAI for TKA patients? Participants will be assigned to one of the following groups at random: * ACB/PACK with PAI * ACB/IPACK with saline injection Participants will also be asked to complete pre- and post-operative questionnaires.

Details

Lead sponsor	Hospital for Special Surgery, New York
Phase	PHASE4
Status	COMPLETED
Enrolment	94
Start date	Thu Dec 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jul 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Total Knee Athroplasty

Interventions

Periarticular Injection (PAI)
Saline Control Periarticular Injection (PAI)

Countries

United States